Polypharmacy and premature aromatase inhibitor (AI) discontinuation in older women with breast cancer

MLA

Elizabeth Joyce, et al. “Polypharmacy and Premature Aromatase Inhibitor (AI) Discontinuation in Older Women with Breast Cancer.” Journal of Clinical Oncology, vol. 40, June 2022, p. 6568. EBSCOhost, https://doi.org/10.1200/jco.2022.40.16_suppl.6568.

APA

Elizabeth Joyce, Kelley M. Kidwell, Vered Stearns, Daniel F. Hayes, Anna Maria Storniolo, & Norah Lynn Henry. (2022). Polypharmacy and premature aromatase inhibitor (AI) discontinuation in older women with breast cancer. Journal of Clinical Oncology, 40, 6568. https://doi.org/10.1200/jco.2022.40.16_suppl.6568

Chicago

Elizabeth Joyce, Kelley M. Kidwell, Vered Stearns, Daniel F. Hayes, Anna Maria Storniolo, and Norah Lynn Henry. 2022. “Polypharmacy and Premature Aromatase Inhibitor (AI) Discontinuation in Older Women with Breast Cancer.” Journal of Clinical Oncology 40 (June): 6568. doi:10.1200/jco.2022.40.16_suppl.6568.